Genscript Biotech Corporation (FRA:G51)

Genscript Biotech Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,455	2,623	4,883	6,308	8,175	2,323
Market Cap Growth	36.62%	-46.28%	-22.58%	-22.84%	251.89%	-38.84%
Enterprise Value	3,122	2,351	4,403	5,721	7,301	1,564
Last Close Price	1.55	1.20	2.23	2.95	3.56	1.15
PE Ratio	1.30	0.92	-	-	-	-
PS Ratio	4.90	4.57	9.63	10.77	18.97	7.27
PB Ratio	0.92	0.63	2.64	4.95	6.70	3.48
P/TBV Ratio	0.92	0.63	3.94	6.85	9.25	3.30
P/FCF Ratio	31.61	-	-	-	-	-
P/OCF Ratio	17.77	35.90	-	-	-	-
EV/Sales Ratio	4.36	4.09	8.68	9.77	16.94	4.90
EV/EBITDA Ratio	194.76	34.75	58.29	-	-	-
EV/EBIT Ratio	-	262.23	185.81	-	-	-
EV/FCF Ratio	28.57	-	-	-	-	-
Debt / Equity Ratio	0.12	0.17	0.41	0.48	0.30	0.07
Debt / EBITDA Ratio	2.20	8.51	8.59	-	-	-
Debt / FCF Ratio	4.27	-	-	-	-	-
Asset Turnover	0.19	0.14	0.19	0.26	0.27	0.34
Inventory Turnover	8.23	7.64	5.12	6.17	5.46	5.60
Quick Ratio	1.78	2.46	4.50	2.99	3.80	2.85
Current Ratio	1.96	2.72	4.76	3.23	3.97	3.03
Return on Equity (ROE)	-1.94%	-5.46%	9.56%	-31.12%	-47.05%	-47.38%
Return on Assets (ROA)	2.56%	0.13%	0.55%	-11.45%	-12.88%	-10.94%
Return on Capital (ROIC)	2.88%	0.15%	0.67%	-14.32%	-17.72%	-20.18%
Return on Capital Employed (ROCE)	3.70%	0.20%	0.90%	-21.90%	-20.80%	-18.30%
Earnings Yield	76.68%	109.05%	-1.77%	-3.36%	-3.86%	-7.21%
FCF Yield	3.16%	-4.42%	-9.99%	-4.99%	-2.90%	-9.61%
Buyback Yield / Dilution	-4.08%	-3.27%	-0.58%	-3.28%	-6.83%	-2.53%
Total Shareholder Return	-4.08%	-3.27%	-0.58%	-3.28%	-6.83%	-2.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.